sabato, Luglio 20, 2024

Le allergie ai legumi: dai più comuni ai meno impiegati, cambiando i tempi cambiano anche le prospettive

Crescente popolarità degli alimenti a base vegetale I legumi sono...

Caffé in clinica: può essere utile per gestire o prevenire la policistosi ovarica? Uno studio di caso-controllo

Le donne con ovaio policistico (PCOS) spesso soffrono di...

Lipoproteins and cardiovascular risk: how to manage the situation with old and new opportunities

What are lipoproteins? Dietary lipids are digested within the gastrointestinal...

The sick gene “shifts the skin”: the case for AEC syndrome

The origin of many diseases lies in the genetic anomalies that cause malfunctions in the proteins that encode. A well-known and widely studied example is p53, a tumor suppressor protein (tumor suppressor). The inactivation of p53 is one of the first stages in the development of a tumor. Mutations in the p63 homologous protein, however, lead to a group of syndromes characterized by defects in embryonic development. The p63 transcription factor works in stem cells of the upper skin (epidermis) and regulates their development and proliferation. Heterozygous mutations in p63 (TP63) are causative of a group of autosomal dominant human disorders characterized by various combinations of ectodermal dysplasia, orofacial clefting, and limb malformations. Among these disorders, ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome is mainly characterized by severe ectrodactyly and limb defects, whereas in ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (AEC), the distinguishing features are ankyloblepharon, congenital erythroderma, skin fragility, atrophy, palmoplantar hyperkeratosis, and extensive skin erosions. Distinct p63 mutations can also cause nonsyndromic diseases, including isolated split hand/foot malformation (SHFM4) 

Mutations in a certain part of the protein are responsible for the potentially lethal ankyloblefaro disorder – ectodermal dysplasia – clefting (AEC syndrome), which is characterized, for example, by cleft palate and long-lasting skin erosions similar to severe burns. Some symptoms may be remedied or alleviated with surgery, but so far no approach to treating the cause has been possible due to the lack of knowledge about the mutated p63 molecules. Scientists at Goethe University in Frankfurt, in collaboration with a research group at the University of Naples Federico II, have now discovered that this syndrome resembles diseases such as Alzheimer’s, Parkinson’s or ALS compared to other p63-based syndromes. Their results, which were recently published in the scientific journal Proceedings of the National Academy of Sciences (PNAS), lay the groundwork for the development of new therapies. The mutations that cause the cluster of AEC syndrome in two domains of the p63 protein do not overlap with those of the other syndromes associated with it. Because these domains are known to be a platform for protein-protein interactions, it has so far been hypothesized that the disorder is triggered through a loss of such interactions.

The biological significance of this interaction remains to be determined. Since p63 is an abundantly expressed transcription factor in keratinocytes, and AEC mutants often show a longer half-life in cells than the wild-type protein, mutant p63 may be able to sequester other nuclear proteins. Aggregation between AEC mutants and p73 and/or other p63 protein partners helps explain the severe skin phenotype specifically observed in AEC syndrome and not in other diseases associated with p63 mutations. “Instead, we were able to demonstrate that mutations within p63 expose sequences of hydrophobic amino acids that attach to each other in the cell and form large unstructured complexes (aggregates similar to the beta-amyloid in Alzheimer’s). This leads to the loss of the function of p63 as a stem cell factor”, explains Professor Volker Dötsch from the Institute of Biophysical Chemistry at the Goethe University in Frankfurt. Similar types of protein aggregates also cause other diseases, such as Parkinson’s, Alzheimer’s, or ALS. Researchers were also able to demonstrate that p63 resumes its activity once aggregate formation is blocked. 

A great variety of biological, biochemical, biophysical and cellular methods were needed as well as a mouse model of the disorder to decipher this new mechanism in detail. A success that was only possible thanks to the close and interdisciplinary collaboration with the research group led by Professor Caterina Missero at the University of Naples Federico II. 

  • a cura del Dr. Gianfrancesco Cormaci, PhD, specialista in Biochimica Clinica.

Scientific references

Russo C et al., Missero C. PNAS USA. 2018 Jan; 115(5):E906-E915. 

Busa T et al., Touraine R. Am J Med Genet A. 2017;173(11):3114-17.

Richardson R et al. PLoS Genet. 2017 Jun 12; 13(6):e1006828.

Khandelwal KD, Ockeloen CW et al. Am J Med Genet. 2017 May 17. 

Latest

Le allergie ai legumi: dai più comuni ai meno impiegati, cambiando i tempi cambiano anche le prospettive

Crescente popolarità degli alimenti a base vegetale I legumi sono...

Lipoproteins and cardiovascular risk: how to manage the situation with old and new opportunities

What are lipoproteins? Dietary lipids are digested within the gastrointestinal...

Metodiche ecografiche per la diagnosi e la gestione temporale del tumore epatico

Il carcinoma epatocellulare (CEP) è un tumore maligno primario...

Newsletter

Don't miss

Le allergie ai legumi: dai più comuni ai meno impiegati, cambiando i tempi cambiano anche le prospettive

Crescente popolarità degli alimenti a base vegetale I legumi sono...

Lipoproteins and cardiovascular risk: how to manage the situation with old and new opportunities

What are lipoproteins? Dietary lipids are digested within the gastrointestinal...

Metodiche ecografiche per la diagnosi e la gestione temporale del tumore epatico

Il carcinoma epatocellulare (CEP) è un tumore maligno primario...

Acido folico nella biologia e nella pratica: per l’anemia, la riproduzione e non solo

L’acido folico è una vitamina del gruppo B che...
Dott. Gianfrancesco Cormaci
Dott. Gianfrancesco Cormaci
Laurea in Medicina e Chirurgia nel 1998, specialista in Biochimica Clinica dal 2002, ha conseguito dottorato in Neurobiologia nel 2006. Ex-ricercatore, ha trascorso 5 anni negli USA alle dipendenze dell' NIH/NIDA e poi della Johns Hopkins University. Guardia medica presso la casa di Cura Sant'Agata a Catania. In libera professione, si occupa di Medicina Preventiva personalizzata e intolleranze alimentari. Detentore di un brevetto per la fabbricazione di sfarinati gluten-free a partire da regolare farina di grano. Responsabile della sezione R&D della CoFood s.r.l. per la ricerca e sviluppo di nuovi prodotti alimentari, inclusi quelli a fini medici speciali.

Sovrappeso e vampate in menopausa: la correlazione è positiva

Sintomi vasomotori (VMS), come vampate di calore e sudorazioni notturne, provocano gravi disagi in molte donne in menopausa. Gli studi mostrano una maggiore frequenza...

La scienza fa il punto: che impatto ha l’esercizio fisico sul benessere di tutti i distretti corporei?

L’importanza dell’attività fisica nella salute umana Gli studi indicano che gli individui che si esercitano regolarmente e raggiungono i livelli raccomandati di attività fisica corrono...

Uridina: la “segretaria” dedicata di fegato e tessuto adiposo

I metaboliti sono sostanze prodotte da un processo metabolico, come il glucosio generato nel metabolismo di zuccheri complessi e amidi, o gli amminoacidi utilizzati...

Questo si chiuderà in 20 secondi